National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

mifepristone
A derivative of the synthetic progestin norethindrone with antiprogesterone activity. Mifepristone competitively binds to the progesterone receptor, resulting in inhibition of the effects of endogenous or exogenous progesterone. This agent also exhibits antiglucocorticoid and weak antiandrogenic activities. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand name:Mifeprex
Foreign brand name:Mifegyne
Code names:RU 486
RU-38486
Chemical structure names:
  • (aa Beta, 17 beta)-11-[4-(dimethylamino)-phenyl]-17-hydroxy-17-(1-propynyl)estra-4,9-dien-3-one
  • 11 beta-[4-(N,N-dimethylamino)phenyl]-17alpha-(propyl-1-ynyl)-delta-4,9-estradiene-17 beta-ol-3-one
  • 11-((4-dimethylamino) phenyl)-17-Hydroxy-17-(1-propynyl) estra-4,9- dien-3-one



Previous:micronutrient-fortified probiotic yogurt, microtubulin inhibitor EPC2407, midazolam hydrochloride, midostaurin, Mifeprex
Next:Milestrol, Milk of Magnesia, milk protein-based energy drink, milk thistle, milodistim

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov